Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Steroids in Tuberculous Lymphadenitis
NCT06236152Completed
- Start
- Jul 2022
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of prednisolone in tuberculous lymphadenitis (TBL) (2 arms). Primary endpoint: Regression of size of cervical lymph nodes. Started Jul 2022; status: completed.
02
Drugs
prednisolone
03
Conditions
tuberculous lymphadenitis (TBL)
Beyond the preview
Go deeper on NCT06236152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06236152.